Literature DB >> 20813131

The roles of TNF in brain dysfunction and disease.

Ian A Clark1, Lisa M Alleva, Bryce Vissel.   

Abstract

Certain cytokines, the prototype being the highly pleiotropic TNF, have many homeostatic physiological roles, are involved in innate immunity, and cause inflammation when in excess. These cytokines have long been accepted to have central roles in the pathogenesis of systemic or local non-cerebral disease states, whether acute or chronic, and whether or not caused by infectious agents. Over the last decade they have also been appreciated to be broadly important in brain physiology. As in other organs, excessive levels in brain are harmful, and its physiological complexity leads to correspondingly complex dysfunction. This review summarizes the burgeoning literature on this topic, and how the functions of these molecules, particularly TNF, are influencing the outlook of researchers on the pathophysiology of these diseases. Basic brain physiology is thus informing knowledge of the brain dysfunction that characterizes such apparently diverse states as Alzheimer's disease, trauma (mostly, but not only, to the brain), Parkinson's disease, and severe systemic infectious states, including malaria, sepsis, viral diseases and major depression. The implication is that the anti-cytokine therapies now in use, typically directed at TNF, warrant testing in these diseases in circumstances in which the therapeutic agent enters the cerebrospinal fluid. Routinely administering such drugs to patients exhibiting the neurological changes discussed in this review would simply add another organ system to what is already a very successful strategy in the treatment of inflammatory disease at other sites, such as joints, skin and gut. Clearly, the most relevant research is focussed on Alzheimer's disease, but the principles may also apply to other encephalopathies.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20813131     DOI: 10.1016/j.pharmthera.2010.08.007

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  71 in total

Review 1.  Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis.

Authors:  Silvio Romano; Elisa Salustri; Piero Ruscitti; Francesco Carubbi; Maria Penco; Roberto Giacomelli
Journal:  Curr Rheumatol Rep       Date:  2018-11-05       Impact factor: 4.592

Review 2.  Practice advisory: Etanercept for poststroke disability: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Authors:  Gary S Gronseth; Steven R Messé
Journal:  Neurology       Date:  2016-06-07       Impact factor: 9.910

3.  Air pollution impairs cognition, provokes depressive-like behaviors and alters hippocampal cytokine expression and morphology.

Authors:  L K Fonken; X Xu; Z M Weil; G Chen; Q Sun; S Rajagopalan; R J Nelson
Journal:  Mol Psychiatry       Date:  2011-07-05       Impact factor: 15.992

4.  New hope for survivors of stroke and traumatic brain injury.

Authors:  Ian Clark
Journal:  CNS Drugs       Date:  2012-12       Impact factor: 5.749

5.  Author's reply to Page: "Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept".

Authors:  Edward Tobinick
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

Review 6.  Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.

Authors:  Sajad Sarvari; Faezeh Moakedi; Emily Hone; James W Simpkins; Xuefang Ren
Journal:  Metab Brain Dis       Date:  2020-04-15       Impact factor: 3.584

7.  The Effect of Residual Endotoxin Contamination on the Neuroinflammatory Response to Sterilized Intracortical Microelectrodes.

Authors:  Madhumitha Ravikumar; Daniel J Hageman; William H Tomaszewski; Gabriella M Chandra; John L Skousen; Jeffrey R Capadona
Journal:  J Mater Chem B       Date:  2014-05-07       Impact factor: 6.331

Review 8.  Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.

Authors:  Boris Decourt; Debomoy K Lahiri; Marwan N Sabbagh
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

9.  Late anxiety-like behavior and neuroinflammation in mice subjected to sublethal polymicrobial sepsis.

Authors:  Allan C Calsavara; David H Rodrigues; Aline S Miranda; Priscila A Costa; Cristiano X Lima; Márcia C Vilela; Milene A Rachid; Antônio L Teixeira
Journal:  Neurotox Res       Date:  2012-12-06       Impact factor: 3.911

10.  Abnormal gene expression of proinflammatory cytokines and their membrane-bound receptors in the lymphocytes of depressed patients.

Authors:  Hooriyah S Rizavi; Xinguo Ren; Hui Zhang; Runa Bhaumik; Ghanshyam N Pandey
Journal:  Psychiatry Res       Date:  2016-04-22       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.